Financial Daily from THE HINDU group of publications
Wednesday, Mar 22, 2006
Financial Daily from THE HINDU group of publications Wednesday, Mar 22, 2006 |
|
|
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures Marketing - Channels and Franchises Globalpharma ties up with French co for Cetirizine Vimala Vasan
Abu Dhabi , March 21 Globalpharma has announced the finalisation and signing of an out-licensing and supply contract with Ethypharm, a leading French multinational drug delivery company, operating in India through its wholly owned subsidiary Ethypharm LL India, for the marketing and distribution of Cetirizine antihistamine tablets. Under the terms of the agreement, Ethypharm will be responsible for the development of the tablets. This new formulation combines several benefits in terms of acceptability, accuracy of dosing and safety, according to a statement from Globalpharma published by the official Emirates News Agency, WAM. With this new technology, drugs are made easier to swallow and more pleasant to taste. As such, they are well suited to meeting the growing demand from patients and health authorities for the provision of more convenient medicines. Globalpharma is responsible for the marketing and distribution of Cetirizine in the Gulf Cooperation Council markets, under its brand name. Globalpharma Co. LLC is a leading joint venture company in the UAE with majority shareholding from Dubai Investment PJC. "Globalpharma is discussing more deals with Ethypharm to cement its position as the premier pharmaceutical company servicing the GCC area," according to Mr Maged Amer, General Manger of Globalpharma.
More Stories on : Alliances & Joint Ventures | Channels and Franchises | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|